These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10642695)

  • 1. Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum.
    Richter-Hintz D; Schuppe HC; Homey B; Lehmann P; Ruzicka T
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):304-5. PubMed ID: 10642695
    [No Abstract]   [Full Text] [Related]  

  • 2. Is topical monotherapy effective for localized pyoderma gangrenosum?
    Le Cleach L; Moguelet P; Perrin P; Chosidow O
    Arch Dermatol; 2011 Jan; 147(1):101-3. PubMed ID: 21242400
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of localized pyoderma gangrenosum with topical pimecrolimus.
    Cecchi R; Pavesi M; Bartoli L; Brunetti L
    J Cutan Med Surg; 2012; 16(5):295-7. PubMed ID: 22971301
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids.
    Doren EL; Aya-ay ML
    Aesthet Surg J; 2014 Mar; 34(3):394-9. PubMed ID: 24448967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful topical tacrolimus (FK506) therapy in a child with pyoderma gangrenosum.
    Kimble RM; Tickler AK; Nicholls VS; Cleghorn G
    J Pediatr Gastroenterol Nutr; 2002 May; 34(5):555-7. PubMed ID: 12050584
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyoderma gangrenosum successfully treated with topical tacrolimus.
    Napolitano M; Megna M; Patrì A; Monfrecola G; Balato N
    G Ital Dermatol Venereol; 2019 Jun; 154(3):361-363. PubMed ID: 29368849
    [No Abstract]   [Full Text] [Related]  

  • 7. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum.
    Kontos AP; Kerr HA; Fivenson DP; Remishofsky C; Jacobsen G
    Int J Dermatol; 2006 Nov; 45(11):1383-5. PubMed ID: 17076739
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful tacrolimus (FK506) therapy in a child with pyoderma gangrenosum.
    Deckers-Kocken JM; Pasmans SG
    Arch Dis Child; 2005 May; 90(5):531. PubMed ID: 15851442
    [No Abstract]   [Full Text] [Related]  

  • 9. Pustular penile pyoderma gangrenosum successfully treated with topical tacrolimus ointment.
    Larsen CG; Thyssen JP
    Acta Derm Venereol; 2012 Jan; 92(1):104-5. PubMed ID: 21681352
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical tacrolimus for pyoderma gangrenosum.
    Schuppe HC; Homey B; Assmann T; Martens R; Ruzicka T
    Lancet; 1998 Mar; 351(9105):832. PubMed ID: 9519983
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum.
    Jolles S; Niclasse S; Benson E
    Br J Dermatol; 1999 Mar; 140(3):564-5. PubMed ID: 10233301
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%.
    Bellini V; Simonetti S; Lisi P
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):113-5. PubMed ID: 18181988
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of periostomal pyoderma gangrenosum using topical tacrolimus.
    Vidal D; Alomar A
    Br J Dermatol; 2004 Feb; 150(2):387-8. PubMed ID: 14996128
    [No Abstract]   [Full Text] [Related]  

  • 14. Penile pyoderma gangrenosum treated with topical tacrolimus.
    Lally A; Hollowood K; Bunker CB; Turner R
    Arch Dermatol; 2005 Sep; 141(9):1175-6. PubMed ID: 16172330
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic absorption of topical tacrolimus in Pyoderma gangrenosum.
    Pitarch G; Torrijos A; Mahiques L; Sánchez-Carazo JL; Fortea JM
    Acta Derm Venereol; 2006; 86(1):64-5. PubMed ID: 16585995
    [No Abstract]   [Full Text] [Related]  

  • 16. Resolution of pyoderma gangrenosum using tacolimus (FK-506).
    Cooley HM; Castelino D; McNair P; Russell DM; Chohan V; Kay TW
    Aust N Z J Med; 1996 Apr; 26(2):238-9. PubMed ID: 8744629
    [No Abstract]   [Full Text] [Related]  

  • 17. Pyoderma gangrenosum in an infant: A case report and review of the literature.
    Crouse L; McShane D; Morrell DS; Wu EY
    Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone.
    Ciurea AM; Guitart J; Brieva J
    Arch Dermatol; 2010 Jan; 146(1):102-3. PubMed ID: 20083712
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of tacrolimus (FK 506) in idiopathic treatment-resistant pyoderma gangrenosum.
    Weichert G; Sauder DN
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):648-50. PubMed ID: 9777778
    [No Abstract]   [Full Text] [Related]  

  • 20. Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus.
    Lyon CC; Kirby B; Griffiths CE
    Br J Dermatol; 1999 Mar; 140(3):562-4. PubMed ID: 10233300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.